Pharmaceutical Products Companies By Ebitda
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
EBITDA
| EBITDA | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | NWBO | Northwest Biotherapeutics | (0.06) | 3.55 | (0.21) | ||
| 2 | TLX | Telix Pharmaceuticals Limited | 0.07 | 3.29 | 0.23 | ||
| 3 | MNKD | MannKind Corp | (0.23) | 1.91 | (0.44) | ||
| 4 | MAZE | Maze Therapeutics, Common | (0.14) | 5.16 | (0.71) | ||
| 5 | ZYBT | Zhengye Biotechnology Holding | 0.16 | 8.21 | 1.28 | ||
| 6 | DVAX | Dynavax Technologies | 0.09 | 1.47 | 0.13 | ||
| 7 | MEIP | MEI Pharma | 0.00 | 1.95 | 0.00 | ||
| 8 | VCEL | Vericel Corp Ord | (0.11) | 2.55 | (0.27) | ||
| 9 | XOMAP | XOMA Corp | 0.04 | 0.54 | 0.02 | ||
| 10 | XOMAO | XOMA Corporation | 0.06 | 0.27 | 0.02 | ||
| 11 | NAGE | Niagen Bioscience, | 0.10 | 7.34 | 0.70 | ||
| 12 | MTEX | Mannatech Incorporated | 0.00 | 5.61 | (0.01) | ||
| 13 | MNPR | Monopar Therapeutics | 0.12 | 8.26 | 0.99 | ||
| 14 | TVGNW | Tevogen Bio Holdings | 0.06 | 8.61 | 0.50 | ||
| 15 | MDCX | Medicus Pharma Ltd | 0.07 | 8.62 | 0.60 | ||
| 16 | PLRZ | Polyrizon Ltd Ordinary | (0.16) | 9.56 | (1.52) | ||
| 17 | SLXNW | Biomotion Sciences Warrant | 0.18 | 17.79 | 3.11 | ||
| 18 | GELS | Gelteq Limited Ordinary | (0.20) | 6.18 | (1.23) | ||
| 19 | CEROW | CERo Therapeutics Holdings | 0.15 | 20.44 | 2.97 | ||
| 20 | MIRA | MIRA Pharmaceuticals, Common | 0.03 | 5.89 | 0.19 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital. In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.